Symbols

HTFL

Heartflow·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About HTFL

Heartflow, Inc.

A cardiovascular diagnostic medical technology company founded in2007in the United States

Industry

Healthcare Technology

Established Date

Listing Date

08/08/2025

Exchange

NASDAQ Stock Exchange

Full-time Employees

843

Fiscal Year Ends

12-31

Website

www.heartflow.com

Security Type

Common stock

Office address

331 E. Evelyn Avenue, Mountain View, California 94041

Business

Introduction

Heartflow, Inc., was incorporated in 2007 under the laws of the State of Delaware. The company provides artificial intelligence-driven software for diagnosing and managing coronary artery disease. Its Heartflow platform analyzes computed tomography angiography images of coronary arteries to create a personalized 3-D model of the patient's heart, providing insights on blood flow and plaque characteristics to support clinical decision-making.

Company Financials

EPS

HTFL has released its 2025 Q4 earnings. EPS was reported at -0.12, versus the expected -0.15, beating expectations. The chart below visualizes how HTFL has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

HTFL has released its 2025 Q4 earnings report, with revenue of 49.13M, reflecting a YoY change of 40.46%, and net profit of -24.39M, showing a YoY change of 26.02%. The Sankey diagram below clearly presents HTFL's revenue sources and cost distribution.